Guia de Gestão Pré-Operatória do Doente Cirúrgico
Recomendações pré-operatórias e orientação da terapêutica farmacológica individualizada
☑ Coluna esquerda: marque os fármacos do doente
⇕ Células de dia: clique para alternar ✓ ✗ ↓
✏ Qualquer texto sublinhado ou observação: clique para editar
Guia de Gestão Pré-Operatória do Doente Cirúrgico
Recomendações pré-operatórias e orientação da terapêutica farmacológica individualizada
Doente:Nome do doente
Data:__ /__ /____
Hospital:Nome do hospital
Leia com atenção e siga as instruções do seu médico anestesiologista. Em caso de dúvida, contacte o serviço antes da data da operação.
✓Tomar normalmente
✗Não tomar (suspenso)
↓Ajustar dose (ver obs.)
⚠ = não alterar sem orientação médica
✓Tomar normalmente
✗Não tomar (suspenso)
↓Ajustar dose (ver obs.)
⚠ = não alterar sem orientação médica
Referências Bibliográficas
- [1]Halvorsen S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022;43(39):3826–3924.
- [2]Fleisher LA, et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. J Am Coll Cardiol. 2014;64(22):e77–e137.
- [3]Wiles MD, et al. Diabetes and anaesthesia: joint guidelines from the Association of Anaesthetists and Diabetes UK. Anaesthesia. 2023;78(2):245–267.
- [4]American Society of Anesthesiologists. Clinical Practice Advisory regarding preoperative evaluation of patients scheduled for surgery with concerns about use of GLP-1 receptor agonists. ASA. 2023.
- [5]US Food & Drug Administration. FDA Drug Safety Communication: SGLT2 inhibitors and risk of diabetic ketoacidosis. FDA. 2020.
- [6]Douketis JD, et al. Perioperative Management of Antithrombotic Therapy: ACCP Evidence-Based Clinical Practice Guidelines, 10th ed. Chest. 2022;162(5):e207–e243.
- [7]Steffel J, et al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants. Europace. 2021;23(10):1612–1676.
- [8]Narouze S, et al. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications, 2nd ed. Guidelines from ASRA Pain Medicine. Reg Anesth Pain Med. 2018;43(3):225–262.
- [9]Valgimigli M, et al. 2017 ESC Guidelines on dual antiplatelet therapy in coronary artery disease. Eur Heart J. 2018;39(3):213–260.
- [10]Huyse FJ, et al. Psychotropic drugs and the perioperative period: a proposal for a guideline in elective surgery. Psychosomatics. 2006;47(1):8–22.
- [11]Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95(4):434–441.
- [12]Goodman SM, et al. 2022 ACR/AAHKS Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Rheumatol. 2022;74(9):1464–1473.
- [13]Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008;143(12):1222–1226.
- [14]Quaye AN, Zhang Y. Perioperative Management of Buprenorphine: Solving the Conundrum. Pain Med. 2019;20(7):1395–1399.
- [15]Brennan KA, Genever RW. Managing Parkinson’s disease during surgery. BMJ. 2010;341:c5718.
- [16]Faculty of Sexual & Reproductive Healthcare. Venous Thromboembolism (VTE) and Hormonal Contraception. FSRH Clinical Guideline. 2020.
- [17]Pfeifer KJ, et al. Perioperative Management of Endocrine Disorders. Open Access Emerg Med. 2020;12:309–318.
- [18]Chou R, et al. Management of Postoperative Pain: A Clinical Practice Guideline from the American Pain Society, ASRA and ASA. J Pain. 2016;17(2):131–157.
2026 © Marta Magalhães Moreira. Todos os direitos reservados.
Ferramenta de suporte ao acompanhamento peri-operatório do doente cirúrgico. A responsabilidade clínica e legal é exclusiva do médico assistente e respetiva equipa multidisciplinar.